Characteristics of Patients Who Survived 2 Years After Surgery for Spinal Metastases: Can We Avoid Inappropriate Patient Selection?

Author(s):
Verlaan, J.J.; Choi, D.; Versteeg, A.; Albert, T.; Arts, M.; Balabaud, L.; Bunger, C.; Buchowski, J.M.; Chung, C.K.; Coppes, M.H.; Crockard, H.A.; Depreitere, B.; Fehlings, M.G.; Harrop, J.; Kawahara, N.; Kim, E.S.; Lee, C.S.; Leung, Y.; Liu, Z.J.; Martin-Benlloch, A.; Massicotte, E.M.; Mazel, C.; Meyer, B.; Peul, W.; Quraishi, N.A.; Tokuhashi, Y.; Tomita, K.; Ulbricht, C.; Wang, M.; Oner, F.C.
Published
2016
Publication type
Article / Letter to editor

Abstract

Poor performance status at presentation is the strongest indicator of poor short-term survival, whereas low disease load and favorable tumor histology are associated with longer-term survival. (C) 2016 by American Society of Clinical Oncology

Date issued
2016-09-01
Language
English
Publisher
AMER SOC CLINICAL ONCOLOGY
Is part of
Journal of Clinical Oncology (2016), Vol. 34, no. 25, p. 3054-+
hdl
1887/99443
doi
10.1200/JCO.2015.65.1497